InspireMD (NSPR) Revenue & Revenue Breakdown
InspireMD Revenue Highlights
Latest Revenue (Y)
$6.21M
Latest Revenue (Q)
$1.74M
InspireMD Revenue by Period
InspireMD Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $6.21M | 20.00% |
| 2022-12-31 | $5.17M | 15.04% |
| 2021-12-31 | $4.50M | 80.89% |
| 2020-12-31 | $2.48M | -33.22% |
| 2019-12-31 | $3.72M | 3.33% |
| 2018-12-31 | $3.60M | 30.42% |
| 2017-12-31 | $2.76M | 45.78% |
| 2016-12-31 | $1.89M | -18.01% |
| 2015-12-31 | $2.31M | -18.03% |
| 2014-12-31 | $2.82M | -42.17% |
| 2013-06-30 | $4.87M | -8.90% |
| 2012-06-30 | $5.35M | -10.91% |
| 2011-12-31 | $6.00M | 100.00% |
| 2010-06-30 | - | 100.00% |
| 2009-06-30 | - | - |
InspireMD generated $6.21M in revenue during NA 2023, up 20.00% compared to the previous quarter, and up 172.31% compared to the same period a year ago.
InspireMD Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $1.74M | 15.09% |
| 2024-03-31 | $1.51M | -14.20% |
| 2023-12-31 | $1.76M | 13.17% |
| 2023-09-30 | $1.56M | -5.64% |
| 2023-06-30 | $1.65M | 33.09% |
| 2023-03-31 | $1.24M | 20.76% |
| 2022-12-31 | $1.03M | -28.30% |
| 2022-09-30 | $1.43M | -6.53% |
| 2022-06-30 | $1.53M | 29.42% |
| 2022-03-31 | $1.18M | -14.28% |
| 2021-12-31 | $1.38M | 28.85% |
| 2021-09-30 | $1.07M | 3.18% |
| 2021-06-30 | $1.04M | 3.18% |
| 2021-03-31 | $1.01M | 536.71% |
| 2020-12-31 | $158.00K | -83.88% |
| 2020-09-30 | $980.00K | 213.10% |
| 2020-06-30 | $313.00K | -69.73% |
| 2020-03-31 | $1.03M | 2.07% |
| 2019-12-31 | $1.01M | 7.88% |
| 2019-09-30 | $939.00K | -30.65% |
| 2019-06-30 | $1.35M | 226.27% |
| 2019-03-31 | $415.00K | -49.51% |
| 2018-12-31 | $822.00K | 6.89% |
| 2018-09-30 | $769.00K | -23.33% |
| 2018-06-30 | $1.00M | -0.40% |
| 2018-03-31 | $1.01M | 20.89% |
| 2017-12-31 | $833.00K | 16.02% |
| 2017-09-30 | $718.00K | 12.19% |
| 2017-06-30 | $640.00K | 12.48% |
| 2017-03-31 | $569.00K | 76.71% |
| 2016-12-31 | $322.00K | -31.34% |
| 2016-09-30 | $469.00K | -13.15% |
| 2016-06-30 | $540.00K | -4.09% |
| 2016-03-31 | $563.00K | 9.11% |
| 2015-12-31 | $516.00K | -18.35% |
| 2015-09-30 | $632.00K | -7.74% |
| 2015-06-30 | $685.00K | 43.61% |
| 2015-03-31 | $477.00K | -45.17% |
| 2014-12-31 | $870.00K | 218.68% |
| 2014-09-30 | $273.00K | 41.45% |
| 2014-06-30 | $193.00K | -86.98% |
| 2014-03-31 | $1.48M | -4.51% |
| 2013-09-30 | $1.55M | 3.47% |
| 2013-06-30 | $1.50M | -0.92% |
| 2013-03-31 | $1.51M | 12.15% |
| 2012-12-31 | $1.35M | 165.23% |
| 2012-09-30 | $509.00K | -45.27% |
| 2012-06-30 | $930.00K | -18.28% |
| 2012-03-31 | $1.14M | -11.92% |
| 2011-12-31 | $1.29M | -34.94% |
| 2011-09-30 | $1.99M | 90.96% |
| 2011-06-30 | $1.04M | -38.32% |
| 2011-03-31 | $1.69M | 100.00% |
| 2010-12-31 | - | 100.00% |
| 2010-09-30 | - | 100.00% |
| 2010-06-30 | - | 100.00% |
| 2010-03-31 | - | 100.00% |
| 2009-12-31 | - | 100.00% |
| 2009-09-30 | - | 100.00% |
| 2009-06-30 | - | 100.00% |
| 2009-03-31 | - | - |
InspireMD generated $1.74M in revenue during Q2 2024, up 15.09% compared to the previous quarter, and up 140.36% compared to the same period a year ago.
InspireMD Revenue Breakdown
InspireMD Revenue Breakdown by Country
Quarterly Revenue by Country
| Country | Jun 24 | Mar 24 |
|---|---|---|
| POLAND | $207.00K | $152.00K |
| Other Countries | $961.00K | $822.00K |
| ITALY | $264.00K | $295.00K |
| GERMANY | $307.00K | $242.00K |
InspireMD's latest quarterly revenue breakdown by geography, as of Jun 24: Other Countries (55.26%), GERMANY (17.65%), ITALY (15.18%), and POLAND (11.90%).
InspireMD Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| SRDX | Surmodics | $132.58M | $30.34M |
| SGHT | Sight Sciences | $81.06M | $21.37M |
| VAPO | Vapotherm | $68.67M | $16.88M |
| NPCE | NeuroPace | $65.42M | $18.12M |
| IRIX | IRIDEX | $51.87M | $12.63M |
| AZYO | Elutia | $49.19M | $6.13M |
| LNSR | LENSAR | $42.16M | $10.59M |
| SSKN | STRATA Skin Sciences | $33.36M | $8.44M |
| RPID | Rapid Micro Biosystems | $22.52M | $6.62M |
| VVOS | Vivos Therapeutics | $13.80M | $4.05M |
| NUWE | Nuwellis | $8.86M | $2.19M |
| RSLS | ReShape Lifesciences | $8.68M | $1.97M |
| NSPR | InspireMD | $6.21M | $1.74M |
| INVO | INVO Bioscience | $3.02M | $1.58M |
| TNON | Tenon Medical | $2.93M | $719.00K |
| TIVC | Tivic Health Systems | $1.18M | $140.00K |
| TLIS | Talis Biomedical | $412.00K | - |
| AIMD | Ainos | $122.11K | - |
| BJDX | Bluejay Diagnostics | - | - |
| BBLG | Bone Biologics | - | - |
NSPR Revenue FAQ
What is InspireMD’s yearly revenue?
InspireMD's yearly revenue for 2023 was $6.2M, representing an increase of 20.00% compared to 2022. The company's yearly revenue for 2022 was $5.17M, representing an increase of 15.04% compared to 2021. NSPR's yearly revenue for 2021 was $4.5M, representing an increase of 80.89% compared to 2020.
What is InspireMD’s quarterly revenue?
InspireMD's quarterly revenue for Q2 2024 was $1.74M, a 15.09% increase from the previous quarter (Q1 2024), and a 5.46% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $1.51M, a -14.20% decrease from the previous quarter (Q4 2023), and a 21.95% increase year-over-year (Q1 2023). NSPR's quarterly revenue for Q4 2023 was $1.76M, a 13.17% increase from the previous quarter (Q3 2023), and a 71.64% increase year-over-year (Q4 2022).
What is InspireMD’s revenue growth rate?
InspireMD's revenue growth rate for the last 3 years (2021-2023) was 38.04%, and for the last 5 years (2019-2023) was 66.76%.